NCT04155567View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-123 After Intravenous Infusion in Japanese Healthy Adult Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 13, 2019

Primary Completion Date

December 6, 2019

Study Completion Date

December 6, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

TAK-123

TAK-123 infusion

Trial Locations (1)

Unknown

Sekino Clinical Pharmacology Clinic, Toshima-ku

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT04155567 - A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-123 After Intravenous Infusion in Japanese Healthy Adult Male Participants | Biotech Hunter | Biotech Hunter